First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
Clinical trial NCT03482648 · COMPLETED
Trial details
- NCT number
- NCT03482648
- Sponsor
- Bridge Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2018-09-26
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.